- Home
- NAII vs CRIS Comparison
NAII vs CRIS Comparison
Compare NAII & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAII
- CRIS
- Stock Information
- Founded
- NAII 1980
- CRIS 2000
- Country
- NAII United States
- CRIS United States
- Employees
- NAII N/A
- CRIS N/A
- Industry
- NAII Medicinal Chemicals and Botanical Products
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NAII Health Care
- CRIS Health Care
- Exchange
- NAII Nasdaq
- CRIS Nasdaq
- Market Cap
- NAII 21.2M
- CRIS 22.9M
- IPO Year
- NAII 1987
- CRIS 2000
- Fundamental
- Price
- NAII $2.63
- CRIS $1.58
- Analyst Decision
- NAII
- CRIS Strong Buy
- Analyst Count
- NAII 0
- CRIS 2
- Target Price
- NAII N/A
- CRIS $16.50
- AVG Volume (30 Days)
- NAII 11.8K
- CRIS 70.2K
- Earning Date
- NAII 11-12-2025
- CRIS 11-13-2025
- Dividend Yield
- NAII N/A
- CRIS N/A
- EPS Growth
- NAII N/A
- CRIS N/A
- EPS
- NAII N/A
- CRIS N/A
- Revenue
- NAII $129,860,000.00
- CRIS $11,405,000.00
- Revenue This Year
- NAII N/A
- CRIS $2.72
- Revenue Next Year
- NAII N/A
- CRIS $8.27
- P/E Ratio
- NAII N/A
- CRIS N/A
- Revenue Growth
- NAII 14.12
- CRIS 12.24
- 52 Week Low
- NAII $2.57
- CRIS $1.02
- 52 Week High
- NAII $4.95
- CRIS $5.45
- Technical
- Relative Strength Index (RSI)
- NAII 39.10
- CRIS 46.80
- Support Level
- NAII $2.60
- CRIS $1.44
- Resistance Level
- NAII $2.78
- CRIS $1.63
- Average True Range (ATR)
- NAII 0.15
- CRIS 0.10
- MACD
- NAII 0.02
- CRIS 0.00
- Stochastic Oscillator
- NAII 16.13
- CRIS 47.61
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.